13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q2 2020. See the latest, Q2 2026 →
Reported value
$909.48B
+26% on the quarter before
Positions
3,959
384 new · 574 sold out
Top 10
27.8%
of the value
Est. gain
+$176.89B
on stocks held all quarter
Est. return
+26.5%
on those stocks since Q1 2020
Positions as of Jun 30, 2020, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 39% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2020. Striped tiles are options.
Largest buys
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Regeneron Pharmaceuticals~$2.49BAdded · 0.6% → 0.9%+3,999,170 shares
- BlackRock~$1.30BAdded · 0.1% → 0.2%+2,388,836 shares
- Nikola Corp~$1.20BNew · 0.0% → 0.1%+18,672,413 shares
- Alibaba~$1.16BAdded · 0.6% → 0.7%+5,388,891 shares
- Pg&E Corp~$985.5MAdded · 0.0% → 0.1%+107,066,900 shares
- T-Mobile Us Inc~$897.2MAdded · 0.4% → 0.5%+8,614,541 shares
- Apple~$893.3MAdded · 3.3% → 3.8%+2,448,814 shares
- Moderna Inc~$820.1MAdded · 0.1% → 0.3%+12,772,752 shares
- Vanguard Index Fds~$802.5MAdded · 0.0% → 0.1%+10,218,923 shares
- Becton Dickinson & Co~$778.4MAdded · 0.3% → 0.3%+3,253,254 shares
Largest sells
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$1.34BCut · 0.3% → 0.1%−48,023,791 shares
- American Express Co~$1.27BCut · 0.2% → 0.1%−13,308,993 shares
- Boston Scientific Corp~$1.23BCut · 0.5% → 0.3%−35,007,643 shares
- General Electric Co~$1.11BCut · 0.7% → 0.3%−163,017,543 shares
- Visa Inc.~$1.05BCut · 1.9% → 1.7%−5,435,797 shares
- Adobe~$1.01BCut · 1.5% → 1.6%−2,325,937 shares
- Vertex Pharmaceuticals Inc~$983.0MCut · 0.7% → 0.6%−3,386,072 shares
- Bk Of America Corp~$860.4MCut · 0.7% → 0.5%−36,227,484 shares
- Altria Group Inc~$818.7MCut · 0.5% → 0.3%−20,858,291 shares
- Alphabet~$759.1MCut · 2.1% → 1.9%−535,320 shares
Holdings
As of Jun 30, 2020. Changes are in shares against Mar 31, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.4% · price +29.0% | 5.3% | $48.21B | +$10.85B | ||||||||
| AmazonCOM · shares +1.3% · price +41.5% | 4.9% | $44.28B | +$12.82B | ||||||||
| AppleCOM · shares +2.6% · price +43.5% | 3.8% | $34.96B | +$10.32B | ||||||||
| MetaCL A · shares −0.2% · price +36.1% | 3.1% | $28.16B | +$7.48B | ||||||||
| NvidiaCOM · shares −1.1% · price +44.1% | 1.9% | $17.67B | +$5.41B | ||||||||
| AlphabetCAP STK CL A · shares −4.2% · price +22.0% | 1.9% | $17.47B | +$3.15B | ||||||||
| Unitedhealth Group IncCOM · shares −0.06% · price +18.3% | 1.8% | $16.29B | +$2.52B | ||||||||
| SalesforceCOM · shares −4.2% · price +30.1% | 1.8% | $16.18B | +$3.74B | ||||||||
| Visa Inc.COM CL A · shares −6.5% · price +19.9% | 1.7% | $15.22B | +$2.52B | ||||||||
| AdobeCOM · shares −6.6% · price +36.8% | 1.6% | $14.27B | +$3.84B | ||||||||
| AlphabetCAP STK CL C · shares −3.5% · price +21.6% | 1.2% | $11.36B | +$2.02B | ||||||||
| MastercardCL A · shares −6.1% · price +22.4% | 1.2% | $10.69B | +$1.96B | ||||||||
| NetflixCOM · shares −1.5% · price +21.2% | 1.1% | $10.03B | +$1.75B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +1.0% · price −1.7% | 0.91% | $8.26B | −$143.9M | ||||||||
| PayPalCOM · shares −5.8% · price +82.0% | 0.91% | $8.24B | +$3.71B | ||||||||
| Regeneron PharmaceuticalsCOM · shares +47% · price +27.7% | 0.85% | $7.77B | +$1.15B | ||||||||
| Shopify IncCL A · shares −6.9% · price +126.8% | 0.85% | $7.76B | +$4.34B | ||||||||
| AlibabaSPONSORED ADS · shares +23% · price +10.9% | 0.69% | $6.29B | +$504.0M | ||||||||
| Lululemon Athletica IncCOM · shares +0.6% · price +64.6% | 0.64% | $5.84B | +$2.28B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares −15% · price +22.0% | 0.62% | $5.59B | +$1.01B | ||||||||
| TeslaCOM · shares +2.0% · price +106.1% | 0.56% | $5.09B | +$2.57B | ||||||||
| Eli LillyCOM · shares +7.0% · price +18.4% | 0.54% | $4.92B | +$713.8M | ||||||||
| Bk Of America CorpCOM · shares −15% · price +11.9% | 0.54% | $4.87B | +$517.2M | ||||||||
| Home Depot IncCOM · shares +2.4% · price +34.2% | 0.53% | $4.78B | +$1.19B | ||||||||
| QualcommCOM · shares −13% · price +34.8% | 0.51% | $4.68B | +$1.21B | ||||||||
| Total · 3,959 positions | 100% | $909.48B | +$176.89B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2020 to Q2 2020: 3,105 stocks held throughout, up $176.89B (+26.5%).
- Amazon+$12.82B+41%
- Microsoft+$10.85B+29%
- Apple+$10.32B+43%
- Meta+$7.48B+36%
- Nvidia+$5.41B+44%
- Novocure Ltd−$83.9M−12%
- Berkshire Hathaway Inc Del−$143.9M−2%
- Edwards Lifesciences Corp2:1 split−$311.6M−27%
- Wells Fargo Co New−$322.2M−11%
- General Electric Co−$508.2M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 16 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |